Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tariquidar multidrug resistance protein 1 NA Successful target TTD , DGIDB Malignant neoplasm of breast[MeSHID:D001943]
Malignant neoplasm of ovary[MeSHID:D010051]
Malignant neoplasm of lung[MeSHID:D008175]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Adrenocortical carcinoma[MeSHID:D018268]		 0.66 discontinued in phase 2 inhibitor
tariquidar multidrug resistance protein 1 NA Successful target TTD , DGIDB Malignant neoplasm of breast[MeSHID:D001943]
Malignant neoplasm of ovary[MeSHID:D010051]
Malignant neoplasm of lung[MeSHID:D008175]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Adrenocortical carcinoma[MeSHID:D018268]		 0.66 discontinued in phase 2 unknown
tariquidar p-glycoprotein 1 small molecule NA drugbank , DGIDB Malignant neoplasm of breast[MeSHID:D001943]
Malignant neoplasm of ovary[MeSHID:D010051]
Malignant neoplasm of lung[MeSHID:D008175]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Adrenocortical carcinoma[MeSHID:D018268]		 0.66 investigational unknown
tariquidar p-glycoprotein 1 small molecule NA drugbank , DGIDB Malignant neoplasm of breast[MeSHID:D001943]
Malignant neoplasm of ovary[MeSHID:D010051]
Malignant neoplasm of lung[MeSHID:D008175]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Adrenocortical carcinoma[MeSHID:D018268]		 0.66 investigational inhibitor
click here to return to the previous page